Cytokines as key players in the pathophysiology of preeclampsia

Medical Principles and Practice

Volumn 22, Issue , 2013, Pages 8-19

  Raghupathy, Raj ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Cytokines; Inflammation; Preeclampsia; Pregnancy; T helper 1; T helper 2

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVATION; EDEMA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE; MATERNAL HYPERTENSION; PATHOGENESIS; PATHOPHYSIOLOGY; PLACENTA DISORDER; PLACENTAL HYPOXIA; PLACENTAL ISCHEMIA; PREECLAMPSIA; PROTEINURIA; REVIEW; TROPHOBLAST;

CYTOKINES; EDEMA; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; PLACENTA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; TROPHOBLASTS;

EID: 84891057044     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000354200     Document Type: Review

References (157)

1. Sibai BM: Hypertensive Disorders in Women. Philadelphia, Saunders, 2004.
2. American College of Obstetricians and Gynecologists: Diagnosis and management of preeclampsia and eclampsia-ACOG practice bulletin No 22. Obstet Gynecol 2002; 99: 159-167.
3. National Heart Lung and Blood Institute: Report of the Working Group on Research on Hypertension during Pregnancy. 2000. http://www.nhlbi.nih.gov/health/prof/heart/hbp/hbp-preg.htm (accessed June 10, 2010).
4. Barron WM: Hypertension; in Barron WM, Lindheimer MD (eds): Medical Disorders during Pregnancy. St. Louis, Mosby Year Book, 1991, pp 1-41.
5. Chang J, Elam-Evans LD, Berg CJ: Pregnancy-related mortality surveillance: United States 1991-1998. MMWR Surveill Summ 2003; 52: 1-8.
6. Leeman L, Fontaine P: Hypertensive disorders of pregnancy. Am Fam Physician 2008; 78: 93-100.
7. Redman CW, Walker I: Preeclampsia: The Facts-The Hidden Threat to Pregnancy. Oxford, Oxford University Press, 1992.
8. Zweifel P: Eklampsie; in Doderlein A (ed): Handbuch der Geburtshilfe. Wiesbaden, Bergmann, 1916, pp 672-723.
9. Maharaj B, Moodley J: Management of hypertension in pregnancy. Contin Med Educ 1994; 12: 1581-1589.
10. Lain KY, Roberts JM: Contemporary concepts of the pathogenesis and management of preeclampsia. J Am Med Assoc 2002; 287: 3183-3186.
11. Saito S: Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunol Cell Biol 2010; 88: 615-617.
12. Sargent IL, Borzychowski AM, Redman CW: Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online 2006; 13: 680-686.
13. Pijnenborg R, Robertson WB, Brosens I, et al: Trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta 1981; 2: 71-91.
14. Robertson WB, Brosens I, Pijnenborg R, et al: The making of the placental bed. Eur J Obstet Gynecol Reprod Biol 1984; 18: 255-266.
15. Gerretsen G, Huisjes HJ, Hardonk MJ, et al: Trophoblast alterations in the placental bed in relation to physiological changes in spiral arteries. Br J Obstet Gynaecol 1983; 90: 34-39.
16. Eastabrook G, Brown M, Sargent I: The origin and end-organ consequence of pre-eclampsia. Best Pract Res Clin Obstet Gynecol 2011; 25: 435-447.
17. Genbacev O, Joslin R, Damsky CH, et al: Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996; 97: 540-550.
18. Zhou Y, Genbacev O, Damsky CH, et al: Oxygen regulates human cytotrophoblast differentiation and invasion: implications for the endovascular invasion in normal pregnancy and in pre-eclampsia. J Reprod Immunol 1998; 39: 197-213.
19. Kingdom JC, Kaufmann P: Oxygen and placental vascular development. Adv Exp Med 1999; 474: 259-275.
20. Roberts JM, Gamill HS: Preeclampsia: recent insights. Hypertension 2005; 46: 1243-1249.
21. De Wolf F, Robertson WB, Brosens I: The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975; 123: 164-174.
22. Kovo M, Schreiber L, Ben-Haroush A, et al: Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol 2010; 202: 561e1-561e5.
23. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594.
24. Sargent IL, Germain SJ, Sacks GP, et al: Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003; 59: 153-160.
25. Aharon A, Brenner B: Microparticles and pregnancy complications. Thrombosis Res 2011; 3: 567-571.
26. Goswami D, Tannetta DA, Magee LA, et al: Syncytiotrophoblast microparticle shedding is a feature of early onset pre-eclampsia but not normotensive intrauterine growth restriction. Placenta 2006; 27: 56-61.
27. Redman CW, Sargent IL: Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008; 29:S73-S77.
28. Kumar S, Lo DY, Smarason AK: Pre-eclampsia is associated with increased levels of circulating apoptotic microparticles and fetal cellfree DNA. J Soc Gynecol Invest 2000; 7:S181a.
29. Cockell AP, Learmont JG, Smarason AK, et al: Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynecol 1997; 104: 235-240.
30. von Dadelszen P, Hurst G, Redman CW: Supernatants from co-cultured endothelial cells and syncytiotrophoblast microvillous membranes activate peripheral blood leukocytes in vitro. Hum Reprod 1999; 14: 919-924.
31. Sargent IL, Johansen M, Chua S, et al: Clinical experience: isolating trophoblast from maternal blood. Ann NY Acad Sci 1994; 731: 154-161.
32. Messarli M, May K, Hansson SR, et al: Fetomaternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Placenta 2010; 31: 106-112.
33. Haeger M, Unander M, Norder-Hansson B, et al: Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 1992; 79: 19-26.
34. Kitzmiller JL: Immunologic approaches to the study of preeclampsia. Clin Obstet Gynecol 1997; 20: 717-735.
35. Clark P, Boswell F, Greer IA: The neutrophil and preeclampsia. Semin Reprod Endocrinol 1998; 16: 57-64.
36. Borzychowski AM, Sargent IL, Redman CW: Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006; 11: 309-316.
37. Sibai BM: Preeclampsia: an inflammatory syndrome? Am J Obstet Gynecol 2004; 191:1061-1066.
38. Saito S, Shiozaki A, Nakashima A, et al: The role of the immune system in preeclampsia. Mol Aspects Med 2007; 28: 192-209.
39. Brewster JA, Orsi NM, Gopichandran N, et al: Gestational effects on host inflammatory response in normal and pre-eclamptic pregnancies. Eur J Obstet Gyneco Reprod Biol 2008; 140: 21-26.
40. Redman CW, Sargent IL: Preeclampsia and the systemic inflammatory response. Semin Nephrol 2004; 24: 565-570.
41. Lamarca BD, Ryan MJ, Gilbert JS, et al: Inflammatory cytokines in the pathophysiology of hypertension during pre-eclampsia. Curr Hypertens Rep 2007; 9: 480-485.
42. Saito S, Sakai M: Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59: 161-173.
43. Knight M, Redman CWG, Linton EA, et al: Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynecol 1998; 105: 632-640.
44. Lim KH, Rice GE, de Groot CJ, et al: Plasma type II phospholipase A2 levels are elevated in severe preeclampsia. Am J Obstet Gynecol 1995; 172: 998-1002.
45. Germain SJ, Sargent IL, Redman CW: C-reactive protein and the maternal inflammatory response in normal pregnancy and pre-eclampsia. Hypertens Preg 2000; 21:S150.
46. Muttukrishna S, North RA, Morris J: Serum inhibin and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000; 15: 1640-1645.
47. Moses EK, Johnson MP, Tammerdal L, et al: Genetic association of preeclampsia to the inflammatory response gene SEPS1. Am J Obstet Gynecol 2008; 198: 336.e1-336.e5.
48. Austgulen R, Lien E, Vince G, et al: Increased maternal plasma levels of soluble adhesion molecules ICAM-1, VCAM-1, E-selectin in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 71: 53-58.
49. Muttukrishna S, North RA, Morris J: Serum inhibin and activin A are elevated prior to the onset of pre-eclampsia. Hum Rerprod 2000; 15: 1640-1645.
50. Kim YM, Romero R, Oh SY: Toll-like receptor 4: a potential link between 'danger signals' the innate immune system, and preeclampsia? Am J Obstet Gynecol 2005; 193: 921-927.
51. Bowen JM, Chamley L, Mitchell MD, et al: Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002; 23: 239-256.
52. Wegmann TG, Lin H, Guilbert L, et al: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14: 353-356.
53. Chaouat G, Meliani AA, Martal J, et al: IL-10 prevents naturally occurring fetal loss in the CBAxDBA/2 mating combination, and local defect in IL-10 production in this abortionprone combination is corrected by in vivo injection of IFN-?. J Immunol 1995; 154: 4261-4268.
54. Chaouat G, Menu E, Clark DA, et al: Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89: 447-458.
55. Yui J, Garcia-Lloret M, Wegmann TG, et al: Cytotoxicity of tumor necrosis factor-? (TNF?) and gamma-interferon (IFN-?) against primary human placental trophoblasts. Placenta 1994; 15: 819-828.
56. Romagnani S: T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000; 85: 9-18.
57. Mosmann TR, Sad S: The expanding universe of T-cell subsets. Immunol Today 1996; 17: 138-146.
58. Hill JA, Anderson DJ, Polgar K: T helper 1-type cellular immunity to trophoblast in women with recurrent spontaneous abortion. J Am Med Assoc 1995; 273: 1933-1936.
59. Raghupathy R, Makhseed M, Azizieh F, et al: Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000; 15: 713-718.
60. Sykes L, MacIntyre DA, Yap XJ, et al: Th1:Th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm 2012; 2012: 967629.
61. Makhseed M, Raghupathy R, El-Shazly S, et al: Proinflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol 2002; 49: 1-12.
62. Raghupathy R, Makhseed M, El-Shazly S, et al: Cytokine patterns in maternal blood after premature rupture of membranes. Obstet Gynecol 2001; 98: 122-126.
63. Arababadi MK, Aminzadeh F, Hassanshahi G, et al: Cytokines in preterm delivery. Lab Med 2011; 43: 27-30.
64. Raghupathy R, Al-Azemi M, Azizieh F: Intrauterine growth restriction: cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes. Clin Dev Immunol 2012; 2012: 734865.
65. Bowen JM, Chamley L, Keelan JA, et al: Cytokines of the placenta and extra-placental membranes: roles and regulation during pregnancy and parturition. Placenta 2002; 23: 257-273.
66. Keelan JA, Mitchell MD: Placental cytokines and preeclampsia. Front Biosci 2007; 12: 2706-2727.
67. Steinborn A, Von Gall C, Hildenbrand R, et al: Identification of placental cytokine-producing cells in term and preterm labor. Obstet Gynecol 1998; 91: 329-335.
68. Jokhi PP, King A, Loke YW: Cytokine production and cytokine receptor expression by cells of the human first trimester placentaluterine interface. Cytokine 1997; 9: 126-137.
69. Montes MJ, Tortosa CG, Borja C, et al: Constitutive secretion of interleukin-6 by human decidual stromal cells in culture: regulatory effect of progesterone. Am J Reprod Immunol 1995; 34: 188-194.
70. Chaouat GA, Cayol V, Mairovitz, et al: Localization of Th2 cytokines IL-3, IL-4, IL-10 at the fetomaternal interface during human and murine pregnancy and lack of requirement for Fas/Fas ligand interaction for a successful allogeneic pregnancy. Am J Reprod Immunol 1999; 42: 1-13.
71. Dimitriadis E, White CA, Jones RL, et al: Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 2005; 11: 613-630.
72. Athanassiades A, Lala PK: Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998; 19: 465-473.
73. Pang ZJ, Xing FQ: Comparative study on the expression of cytokine-receptor genes in normal and preeclamptic human placentas using DNA microarrays. J Perinat Med 2003; 31: 153-162.
74. Benyo DF, Smarason A, Redman CW, et al: Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505-2512.
75. Hung TH, Charnock-Jones DS, Skepper JN, et al: Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004; 164: 1049-1061.
76. Wang Y, Walsh SW: TNF alpha concentrations and mRNA expression are increased in preeclamptic pregnancies. J Reprod Immunol 1996; 32: 157-169.
77. Conrad JP, Benyo DF: Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37: 240-249.
78. Tranquilli AL, Corradetti A, Giannubilo SR, et al: Placental cytokines in the pathogenesis of preeclampsia and HELLP syndrome. Curr Womens Health Rev 2008; 4: 280-285.
79. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S: Expression of the placental cytokines tumor necrosis factor alpha, interleukin-1beta and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181: 915-920.
80. Ahmad S, Ahmad A: Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004; 95: 884-891.
81. Gilbert JS, Ryan MJ, LaMarca BB, et al: Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294:H541-H550.
82. Caniggia I, Winter J, Lye SJ, et al: Oxygen and placental development during the first trimester: implications for the pathophysiology of preeclampsia. Placenta 2000; 21(suppl A):S25-S30.
83. Benyo DF, Miles TM, Conrad K. P: Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997; 82: 1582-1588.
84. Utesheva Z, Kravtsova N, Dzoz L, et al: Cytokine investigations in organs and tissues of experimental animals under prenatal hypoxic conditions of varying sensitivity. Med Health Sci J 2011; 6: 136-140.
85. Huppertz B, Kingdom JC: Apoptosis in the trophoblast-role of apoptosis in placental morphogenesis. J Soc Gynecol Invest 2004; 11: 353-362.
86. Huang X, Huang H, Dong M, et al: Serum and placental interleukin-18 are elevated in preeclampsia. J Reprod Immunol 2005; 65: 77-87.
87. Sakai M, Tsuda H, Tanebe K, et al: Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients. Am J Reprod Immunol 2002 47: 91-97.
88. Sakai M, Shiozaki A, Sasaki Y, et al: The ratio of interleukin (IL)-18 to IL-12 secreted by peripheral blood mononuclear cells is increased in normal pregnant subjects and decreased in pre-eclamptic patients. J Reprod Immunol 2004; 61: 133-143.
89. Lockwood CJ, Yen CF, Basar M, et al: Preeclampsia-related inflammatory cytokines regulate interkeukin-6 expression in human decidual cells. Am J Pathol 2008; 172: 1571-1579.
90. Peng B, Koga K, Cardenas I, et al: Phagocytosis of apoptotic trophoblast cells by human endometrial endothelial cells induces proinflammatory cytokine production. Am J Reprod Immunol 2010; 64: 12-19.
91. Wilczinski JR, Tchorzeski H, Banasik M: Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 109: 8-15.
92. Arriaga-Pizano L, Jimenez-Zamudio L, Vadillo-Ortega F: The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the choriodecidual and fetal compartments. J Soc Gynecol Invest 2005; 12: 335-342.
93. Rein DT, Breidenbach M, Honscheid B, et al: Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 2003; 23: 119-125.
94. Makris A, Xu B, Yu B, et al: Placental deficiency of interleukin-10 (IL-10) in preeclampia and its relationship to IL-10 promoter polymorphism. Placenta 2006; 37: 445-451.
95. Hennessy A, Pilmore HL, Simmons LA, et al: A deficiency of placental IL-10 in preeclampsia. J Immunol 1999; 163: 3491-3495.
96. Crocker IP, Cooper S, Ong SC, et al: Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003; 162: 637-643.
97. Ishihara N, Matsuo H, Murakoshi H, et al: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186: 158-166.
98. Difiderico E, Genbacev O, Fisher SJ: Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999; 155: 293-301.
99. Ahn H, Park J, Gilman-Sachs A, et al: Immunologic characteristics of preeclampsia, a comprehensive review. Am J Reprod Immunol 2011; 65: 377-394.
100. Huang SJ, Zenclussen AC, Chen CP et al: The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia. Am J Pathol 2010; 177: 2472-2482.
101. Vince GS, Starlkey PM, Austgulen R, et al: Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20-25.
102. Conrad K. P, Miles TM, Benyo DF: Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40: 102-111.
103. Kocygit Y, Atamer Y, Atamer A, et al: Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol 2004; 19: 267-273.
104. Serin IS, Ozelik B, Basbug M, et al: Predictive value of tumor necrosis factor alpha (TNFalpha) in preeclampsia. Eur J Obstet Reprod Biol 2002; 100: 143-145.
105. Velzing-Aarts FV, Muskiet FA, van der Dijs FP: High serum interleukin-8 levels in Afro-Caribbean women with preeclampsia: relationships with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor. Am J Reprod Immunol 2002; 48: 319-322.
106. Sacks GP, Studena K, Sargent IL, et al: Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179: 80-86.
107. Chen G, Wilson R, Wang SH, et al: Tumor necrosis factor-? (TNF-?) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104: 154-159.
108. Kupferminc MJ, Peaceman AM, Aderka D, et al: Soluble tumor necrosis factor receptors in maternal plasma and second trimester amniotic fluid. Am J Obstet Gynecol 1995; 173: 900-905.
109. Sibai B, Romero R, Klebanoff MA: Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol 2009; 200: 630.e1-e8.
110. Hamai Y, Fujii T, Yamashita T, et al: Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38: 89-93.
111. Jonsson Y, Ruber M, Matthiesen L, et al: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70: 83-91.
112. Freeman DJ, McManus FM, Brown EA: Short-and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44: 708-714.
113. Nakabayashi M, Sakura M, Takeda Y, et al: Elevated IL-6 mid-trimester amniotic fluid is involved with the onset of preeclampsia. Am J Reprod Immunol 1998; 39: 329-334.
114. Szarka A, Rigo J Jr, Lazar L, et al: Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 2010; 11: 59-64.
115. Omu AE, Al-Qattan F, Diejomaoh ME: Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. Acta Obstet Gynecol Scand 1999; 78: 675-680.
116. Saito S, Umekage Y, Sakamoto M, et al: Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 1999; 41: 297-306.
117. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Goarzelak B: The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol 2002; 48: 381-386.
118. Darmochwal-Kolarz D, Leszczynska-Goarzelak B, Rolinski J: T helper-1 and T helper-2 cytokine imbalance in pregnant women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1999; 86: 165-170.
119. Rein DT, Schondorf T, Gohring UJ: Cytokine expression in peripheral blood lymohocytes indicates a switch in T(helper) cells in patients with preeclampsia. J Reprod Immunol 2002; 54: 133-142.
120. Luppi P, Deloia JA: Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 2006; 118: 268-275.
121. Orange S, Horvath J, Hennessy A: Preeclampsia is associated with a reduced interleukin-10 production from peripheral blood mononuclear cells. Hypertens Pregnacy 2003; 22: 1-8.
122. Azizieh F, Raghupathy R, Makhseed M: Maternal cytokine production patterns in women with pre-eclampsia. Am J Reprod Immunol 2005; 54: 30-37.
123. Darmochwal-Kolarz D, Saito S, Rolinski J, et al: Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol 2007; 58: 39-45.
124. Saito S, Sakai M, Sasaki Y, et al: Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117: 550-555.
125. Zenclussen AC: A novel mouse model for preeclampsia by transferring activated th1 cells into normal pregnant mice. Methods Mol Med 2006; 122: 401-412.
126. Germain SJ, Sacks GP, Sooranna SR, et al: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178: 5949-5956.
127. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, et al: Proportion of peripheral blood and decidual CD4+ CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol 2007; 149: 139-145.
128. Santner-Nanan B, Peek MJ, Khanam R, et al: Systemic increase in the ratio between Foxp3 + and IL-17-producing CD4 + T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009; 183: 7023-7030.
129. Paeschke S, Chen F, Horn N, et al: Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am J Reprod Immunol 2005; 54: 384-389.
130. Sibai BM: Initiators of severe pre-eclampsia: Semin Perinatol 2009; 33: 196-205.
131. Redman CW, Sacks GP, Sargent IL: Preeclampsia: an excessive maternal response to pregnancy, Am J Obstet Gynecol 1999; 180: 499-506.
132. Chen LM, Liu B, Zhao HP, et al: IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. Placenta 2010; 31: 75-80.
133. Kharfi A, Giguere Y, Sapin V, et al: Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin Biochem 2003; 36: 323-331.
134. Kofler S, Nickel T, Weis M: Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond) 2005; 108: 205-213.
135. Naldini A, Carraro F: Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 2005; 4: 3-8.
136. Kaplansjuki G, Fabrigoule M, Boulay V: Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression,-alpha-independent IL-8 secretion and E-selectin expression. J Immunol 1997; 158: 5435-5441.
137. Madazli R, Aydin S, Uludag S, et al: Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82: 797-802.
138. Granger JP, Alexander BT, Llinas T, et al: Pathophysiology of preeclampsia linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9: 147-160.
139. Granger JP: Inflammatory cytokines, vascular function and hypertension. Am J Physiol Regul Integr Comp Physiol 2004; 286:R989-R990.
140. Claman JY, Rapaport V, Repinski C, et al: Analysis of superoxide generation, cytokine production, and adhesion molecular production in normal pregnant and preeclamptic patients. J Soc Gynecol Investig 1997; 4:S192A.
141. Zenclussen AC, Lim E, Knoeller S, et al: Heme oxygenases in pregnancy II: HO-2 is downregulated in human pathologic pregnancies. Am J Reprod Immunol 2003; 50: 66-76.
142. Wong RJ, Zhao H, Stevenson DK: A deficiency in haem oxygenase-1 induces foetal growth restriction by placental vasculature defects. Acta Paediatr 2012; 101: 827-834.
143. Zhao H, Wong RJ, Kalish FS, et al: Effect of heme oxygenase-1 deficiency on placental development. Placenta 2009; 30: 861-868.
144. Hayashi M, Inoue T, Hoshimoto K, et al: Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and preeclampsia. Eur J Haematol 2002; 69: 297-302.
145. Sibai BM: Initiators of severe pre-eclampsia. Semin Perinatol 2009; 33: 196-205.
146. George EM, Granger JP: Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens 2011; 24: 964-969.
147. Leibowitz A, Schiffrin EL: Immune mechanisms in hypertension. Curr Hypertens Rep 2011; 13: 465-472.
148. Tinsley JH, Chiasson VL, South S, et al: Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension. Am J Hypertens 2009; 22: 1107-1114.
149. Saito S, Nakashima A, Shima T, et al: Th1, Th2, Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 63: 601-610.
150. Taslinipar A, Yaman H, Yilmaz MI, et al: Relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy. Scand J Clin Lab Invest 2011; 71: 606-612.
151. Orange S, Rasko JE, Thomson JF, et al: Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine 2009; 29: 176-185.
152. Chatterjee P, Chiasson VL, Kopriva SE, et al: Interleukin-10 deficiency exacerbates Tolllike receptor 3-induced preeclampsia-like symptoms in mice. Hypertension 2011;58: 489-496.
153. White CA, Johansson M, Roberts CT, et al: Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod 2004; 70: 123-131.
154. Keiser SD, Veillon EW, Parrish MR, et al: Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am J Hypertens 2009; 22: 1120-1125.
155. Raghupathy R, Al Mutawa E, Makhseed M, et al: Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. Br J Obstet Gynecol 2005; 112: 1096-1101.
156. Raghupathy R, Al Mutawa E, Makhseed M, et al: Redirection of cytokine production by lymphocytes from women with pre-term delivery by dydrogesterone. Am J Reprod Immunol 2007; 58: 31-38.
157. Raghupathy R, Kalinka J: Cytokine imbalance in pregnancy complications and its modulation. Front Biosci 2008; 13: 985-994.